Compare StocksPFE vs TRV

Pfizer Inc. (PFE) vs The Travelers Companies, Inc. (TRV): Which Is the Better Buy in 2026?

As of 2026-06-19, PFE is overvalued at $25, with a DCF intrinsic value of $22 and a margin of safety of -12%. TRV is undervalued at $308, with an intrinsic value of $443 and a margin of safety of 30%. Of the two, TRV has the wider margin of safety.

PFE
Pfizer Inc.
$25.21
VS
TRV
The Travelers Companies, Inc.
$307.81

Rewards

PFE
  • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • FCF yield of 8.6% is historically attractive — the business generates significant cash relative to its price.
  • Trailing P/E of 19.2x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.
TRV
  • The Travelers Companies, Inc. scores 100/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Free cash flow has grown at a 17.9% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Each dollar of retained earnings has created $3.35 of earning power — management is an exceptional capital allocator.

Risks

PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • PEG ratio of 13.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Free cash flow has declined at a 29.6% CAGR over the past 4 years — a concerning trend.
TRV
  • PEG ratio of 2.36 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 1.22 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • 7 insider sales totaling $12.8M with no purchases in the past 3 months — insiders are reducing their exposure.

Key Valuation Metrics

Learn more →
PFE
TRV
Valuation
$12.38B
Free Cash Flow
$13.30B
8.61%
FCF Yield
20.33%
19.24
Trailing P/E
9.16
8.91
Forward P/E
10.78
Quality & Moat
10.19%
ROIC
17.57%
8.31%
ROE
25.27%
74.80%
Gross Margin
32.88%
13.77
PEG Ratio
2.36
Balance Sheet Safety
0.57
Net Debt / Equity
0.07
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
0.20
6.61%
Dividend Yield
1.63%
PFE: 3Ties: 1TRV: 8
PFETRV

Historical Fundamentals

Learn more →
PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

TRV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-146.18B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
TRV
$1.71
created per $1 retained over 3 years
Value Creator
Σ Retained
$11.44B
Δ Market Cap
+$19.57B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
PFE
12.3% Overvalued
Price is 12.3% above estimated fair value
Current Price: $25.21
Fair Value: $22.46
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
TRV
30.5% Margin of Safety
Price is 30.5% below estimated fair value
Current Price: $307.81
Fair Value: $442.69
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
PFE

What growth rate is the market pricing in at $25?

+5.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +4.5%

The market implies +5.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +4.5%, reflecting heavy growth investment.

TRV

What growth rate is the market pricing in at $308?

-0.8%
Market-Implied Owner Earnings Growth
Standard FCF implies -11.9%

The market implies -0.8% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding -11.9%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
TRV
100/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Reinvestment Efficiency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
TRV
-2.66
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
PFE
Insiders 0.1%Institutions 69.4%Retail & Other 30.5%
No. of Institutional Holders3,744
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
TRV
Insiders 0.3%Institutions 87.9%Retail & Other 11.8%
No. of Institutional Holders2,314
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
PFE
0
Buys (3M)
0
Buys (12M)
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises
TRV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
PFE
1
Sells (3M)
1
Sells (12M)
Total value (12M): $51,400
DAMICO JENNIFER B.
Officer
$51,400
@ $25.70 · 2026-06-09
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
DAMICO JENNIFER B.
Officer
$147,714
@ $28.66 · 2024-08-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
TRV
7
Sells (3M)
36
Sells (12M)
Total value (12M): $93.05M
KLEIN MICHAEL FREDERICK
Officer
$3.08M
@ $307.65 · 2026-05-26
BESSETTE ANDY F
Officer
$1.31M
@ $308.11 · 2026-05-22
HEYMAN WILLIAM H
Officer
$483,670
@ $310.64 · 2026-04-28
KESS AVROHOM J
Officer
$2.08M
@ $308.78 · 2026-04-28
KURTZMAN DIANE
Officer
$869,980
@ $303.45 · 2026-04-20
KLENK JEFFREY P
Officer
$1.96M
@ $305.09 · 2026-04-20
KLEIN MICHAEL FREDERICK
Officer
$3.04M
@ $303.77 · 2026-04-20
ROWLAND DAVID DONNAY
Chief Investment Officer
$1.46M
@ $308.52 · 2026-02-26
OLIVO MARIA
Officer
$3.19M
@ $306.60 · 2026-02-26
MUNSON PAUL E
Officer
$1.14M
@ $306.04 · 2026-02-25
HEYMAN WILLIAM H
Officer
$1.53M
@ $306.75 · 2026-02-23
TOCZYDLOWSKI GREGORY C
Officer
$3.66M
@ $299.78 · 2026-02-20
KESS AVROHOM J
Officer
$1.43M
@ $300.44 · 2026-02-20
FREY DANIEL S.
Chief Financial Officer
$2.40M
@ $299.50 · 2026-02-20
LEFEBVRE MOJGAN M
Officer
$1.74M
@ $298.29 · 2026-02-19
HEYMAN WILLIAM H
Officer
$300,000
@ $300.00 · 2026-02-17
BESSETTE ANDY F
Officer
$1.79M
@ $297.65 · 2026-02-17
HEYMAN WILLIAM H
Officer
$1.81M
@ $302.17 · 2026-02-06
OLIVO MARIA
Officer
$3.13M
@ $300.75 · 2026-02-06
KLEIN MICHAEL FREDERICK
Officer
$3.01M
@ $301.18 · 2026-02-06
SCHNITZER ALAN D
Chief Executive Officer
$16.42M
@ $294.70 · 2026-02-04
KLENK JEFFREY P
Officer
$4.68M
@ $279.77 · 2026-01-23
OLIVO MARIA
Officer
$2.64M
@ $295.73 · 2025-11-26
HEYMAN WILLIAM H
Officer
$1.18M
@ $294.50 · 2025-11-25
KURTZMAN DIANE
Officer
$1.39M
@ $290.00 · 2025-11-24
HEYMAN WILLIAM H
Officer
$583,000
@ $291.50 · 2025-11-21
ROWLAND DAVID DONNAY
Chief Investment Officer
$1.45M
@ $290.57 · 2025-11-21
HEYMAN WILLIAM H
Officer
$1.10M
@ $288.47 · 2025-11-13
HEYMAN WILLIAM H
Officer
$1.98M
@ $283.11 · 2025-11-11
FREY DANIEL S.
Chief Financial Officer
$6.96M
@ $278.25 · 2025-11-06
KLEIN MICHAEL FREDERICK
Officer
$2.32M
@ $270.73 · 2025-10-28
HEYMAN WILLIAM H
Officer
$557,000
@ $278.50 · 2025-08-22
LEFEBVRE MOJGAN M
Chief Operating Officer
$4.67M
@ $277.54 · 2025-08-22
BESSETTE ANDY F
Officer
$2.05M
@ $264.90 · 2025-08-07
KLEIN MICHAEL FREDERICK
Officer
$2.62M
@ $261.99 · 2025-08-04
TOCZYDLOWSKI GREGORY C
Officer
$3.06M
@ $266.12 · 2025-07-21
HEYMAN WILLIAM H
Officer
$553,000
@ $276.50 · 2025-05-30
HEYMAN WILLIAM H
Officer
$549,000
@ $274.50 · 2025-05-29
KURTZMAN DIANE
Officer
$1.09M
@ $273.02 · 2025-05-29
ROWLAND DAVID DONNAY
Chief Investment Officer
$3.31M
@ $274.01 · 2025-05-29
KLENK JEFFREY P
Officer
$4.14M
@ $272.87 · 2025-05-29
MUNSON PAUL E
Officer
$1.11M
@ $273.29 · 2025-05-29
OLIVO MARIA
Officer
$9.93M
@ $274.20 · 2025-05-29
SCHNITZER ALAN D
Chief Executive Officer
$9.71M
@ $273.78 · 2025-05-29
KLEIN MICHAEL FREDERICK
Officer
$2.48M
@ $274.17 · 2025-05-29
KESS AVROHOM J
Officer
$6.42M
@ $273.93 · 2025-05-29
FREY DANIEL S.
Chief Financial Officer
$5.55M
@ $273.48 · 2025-05-29
LEFEBVRE MOJGAN M
Chief Operating Officer
$1.68M
@ $273.74 · 2025-05-29
BESSETTE ANDY F
Officer
$1.36M
@ $272.76 · 2025-05-16
HEYMAN WILLIAM H
Officer
$1.09M
@ $271.50 · 2025-05-08
LEFEBVRE MOJGAN M
Chief Technology Officer
$3.31M
@ $248.60 · 2025-02-26
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
PFE
FearGreed
😐Neutral(49/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
TRV
FearGreed
😏Greed(70/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
TRV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (70)
View PFE Full AnalysisView TRV Full Analysis

Frequently Asked Questions: PFE vs TRV

Is Pfizer Inc. or The Travelers Companies, Inc. more undervalued in 2026?

Based on our discounted cash flow model, TRV trades at a 30.5% margin of safety (intrinsic value $443 vs. price $308), compared to PFE's -12.3% margin of safety (intrinsic $22 vs. $25).

Which stock has a wider economic moat, Pfizer Inc. or The Travelers Companies, Inc.?

TRV scores 100/100 (Wide moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is The Travelers Companies, Inc. in financial distress?

TRV's Altman Z-Score of 1.2 places it in the Distress zone, signaling elevated bankruptcy risk. PFE scores 2.1 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Pfizer Inc. or The Travelers Companies, Inc.?

The Travelers Companies, Inc. (TRV) generates a 20.3% free cash flow yield, compared to Pfizer Inc.'s 8.6%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Pfizer Inc. or The Travelers Companies, Inc.?

TRV earns 17.6% ROIC versus PFE's 10.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Pfizer Inc.'s or The Travelers Companies, Inc.'s?

TRV's dividend earns a safety score of 94/100 (Very Safe), compared to PFE's 24/100 (Unsafe). TRV has raised its dividend for 3 consecutive years.